A presentation by Mike Graffeo, CEO, FluidForm.
The fields of tissue engineering and bioprinting have been hamstrung by challenges using the right materials assembled the way biology intended to recreate structure and function. In this presentation, you’ll learn about some of the work that has been done using the FRESH method to advance the field of tissue engineering.
Question 1: What drives you?
A desire to improve human health
Question 2: Why should the delegate attend your presentation?
If you’re interested in learning how leading scientists all over the world are using FRESH bioprinting to advance their research.
Question 3: What emerging technologies/trends do you see as having the greatest potential in the short and long run?
I’m quite biased, but I believe that FRESH printing is a gamechanger
Question 4: What kind of impact do you expect them to have?
I believe that we’ll see implanted products using this method within 5 years
Question 5: What are the barriers that might stand in the way?
here are barriers including regulatory frameworks as well as the ability to supply stem-cell derived cells by the billions
About Mike Graffeo
Mike is the CEO and co-founder of FluidForm. He has spent the last 20 years in the medical device and combination product industry, launching multiple products around the world. Before co-founding Fluidorm, he held leadership positions in sales, marketing, and business development in startups and mid-cap companies. He has a BS and MEng degrees from Cornell University, and an MBA from Harvard.
FluidForm is advancing the field of tissue engineering using its exclusive FRESH printing technology
Mike is speaker at the 2021 edition of the 3D BioPrinting Conference.